AI
Wednesday, April 16, 2014 10:55:55 PM
~ ENTB = Entest offers a novel and "personalized" approach to cancer therapy that utilizes the body's own defense mechanisms. At the same time, the Company's focus on canine applications provides a platform to launch near-term clinical trials and offers a much faster path to profitability than similar biotech companies that are solely focused on treating the human population. 
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
